Exploring - Never Stop

Research

POZcast focuses on HIV, Fatherhood and Fertility

published: June, 21, 2017 Written by // Ontario HIV Treatment Network - Research Categories // Social Media, OHTN OHTN/PositiveLite.com, Research, Health, Living with HIV, Media, Ontario HIV Treatment Network

From Universities without Walls, a series of informative discussions hosted by James Watson.

POZcast focuses on HIV, Fatherhood and Fertility

Tune in to hear how HIV-positive men and their healthcare providers are talking about fatherhood, and why some men are rethinking their decisions around parenting. James Watson talks to Dr. Mark Yudin, from the University of Toronto, and Logan Kennedy from Women’s College Hospital, about new fertility options, access to stigma-free parenting environments, and why fertility researchers are turning their attention to men. He also talks to Charlie, a Peer Research Associate, who opens up ab

Are you 60-plus? Have your voice heard!

published: June, 14, 2017 Written by // Guest Authors - Revolving Door Categories // Aging, Social Media, As Prevention , General Health, Treatment Guidelines -including when to start, Mental Health, Upcoming Events, Health, Research, Sexual Health, Revolving Door, Treatment, Living with HIV, Guest Authors, Media

Your participation will be of benefit to yourself, service providers, policy makers, the field of social work, gerontology and sexuality and the community in general.

Are you 60-plus? Have your voice heard!

H A V E  Y O U R  V O I C E  H E A R D ! P L E A S E  R S V P  B Y : E M A I L : k i m . w i l s o n @ u o g u e l p h . c a P H O N E : 5 1 9 - 8 2 4 - 4 1 2 0 e x t . 5 3 0 0 3   W E  A R E  L O O K I N G  F O R  V O L U N T E E R S  T O P A R T I C I P A T E  I N  A  F O C U S  G R O U P  J U N E 1 9 ( 2 0 1 7 ) , F O R  2  H O U R S  I N D U R A T I O N ,  T O  H E L P  U S  D E V E L O P  A B E T T E R  U N D E R S T A N D I N G  O F  T H E  L I V E D

Agreements with cash incentives boost patient adherence to HIV therapy and rates of viral suppression

published: June, 12, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Treatment Guidelines -including when to start, General Health, Research, Health, International , Revolving Door, Treatment, Guest Authors, Media

From AIDSmap, Michael Carter reports on a study that demonstrated the feasibility of using commitment contracts in HIV care.

Agreements with cash incentives boost patient adherence to HIV therapy and rates of viral suppression

People who enter into a contract with their HIV healthcare provider to receive cash incentives in return for high levels of antiretroviral therapy (ART) adherence are more likely to achieve sustained viral suppression compared to people in a control arm, investigators from the United States report in the online edition of AIDS. The study recruited individuals with ongoing viral replication despite at least six months of ART. Individuals who entered into a commitment contract were appro

Ontario HIV Treatment Network (OHTN) endorses U=U.

published: May, 17, 2017 Written by // Ontario HIV Treatment Network - Research Categories // Social Media, OHTN OHTN/PositiveLite.com, As Prevention , Current Affairs, Treatment Guidelines -including when to start, General Health, Research, Health, Sexual Health, Treatment

The Ontario HIV Treatment Network: "Acting on this knowledge will drive good public policy and clinical practice – encouraging prompt access to testing, treatment and support, as well as dramatically reducing HIV stigma."

Ontario HIV Treatment Network (OHTN) endorses U=U.

The "Undetectable = Untransmittable" Campaign (U=U) is an international movement. It unites communities of people living with HIV, service organizations and leading HIV researchers in support of a clear, evidence-based consensus statement about the power of effective antiretroviral treatment to prevent the sexual transmission of HIV. The Ontario HIV Treatment Network endorsed the U=U consensus, as follows, on May 15, 2017: The Ontario HIV Treatment Network (OHTN) is funded by the Ministry

Why we still need an HIV vaccine today

published: May, 05, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, General Health, Health, Research, Revolving Door, Guest Authors

"... without an effective vaccine against a virus that constantly mutates and connives to evade the fragile and complex strategies we find to stop it, the prospect of ending new infections is precarious," writes Robert Reinhard

Why we still need an HIV vaccine today

Advocates recognize May 18, 2017 as the 20th anniversary of HIV Vaccine Awareness Day, an important day to mark the need to develop this safe, effective and accessible prevention tool to augment the current biomedical and behavioral prevention options we have now to curb the incidence of new HIV infections in each country. Many ask, “Why is that so when we now have, singly or in strategic combination: oral preexposure prophylaxis, harm reduction, ways to lower a person’s HIV viral load so

Are women prepared for HIV PrEP?

published: May, 05, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, Dating, As Prevention , General Health, Treatment Guidelines -including when to start, Women, Research, International , Revolving Door, Lifestyle, Treatment, Guest Authors

From KALW.org, Chloe Lessard: "some women and trans folks are wondering why a drug that could potentially save their lives hasn’t been aggressively promoted in their communities."

Are women prepared for HIV PrEP?

To read the complete article by Chloe Lessard, visit KALW.org, here. Did you know that you can take a drug to reduce your risk of getting HIV? If you’re a gay man, you’ve probably heard of it. It’s a daily regimen called PrEP, or pre-exposure prophylaxis. Maybe you’ve even seen ads for it on BART trains or clinic brochures, usually targeting men who sleep with other men. But PrEP doesn’t only benefit men, and some women and trans folks are wondering why a drug that could potential

What women want – sexual and reproductive health rights

published: May, 03, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Activism, Current Affairs, Women, Research, Health, International , Sexual Health, Revolving Door, Living with HIV, Guest Authors

From AIDSmap, Greta Hughson reports on the first consolidated guideline on sexual and reproductive health and rights of women living with HIV, recently issued by the World Health Organization (WHO)

What women want – sexual and reproductive health rights

“HIV is not only driven by gender inequality, but it also entrenches gender inequality, leaving women more vulnerable to its impact. Providing sexual and reproductive health interventions for women living with HIV that are grounded in principles of gender equality and human rights can have a positive impact on their quality of life; it is also a step towards long-term improved health status and equity.”  -- WHO Consolidated guideline on sexual and reproductive health and rights of women

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

published: May, 02, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, Health, Research, CATIE - HIV and Hep C Info Resource, Treatment

Sean R. Hosein of CATIE reports on research in Vancouver that attempted to study the relative impact that ART, harm reduction or both can have on the spread of HIV.

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

In clinical trials, the early initiation of HIV treatment (ART) stabilizes the immune system and significantly reduces the risk of developing AIDS-related infections and cancers. This benefit of ART is so profound that researchers increasingly expect that many ART users will live into their senior years. Key to reaping the benefit of ART is achieving an undetectable level of HIV in the blood (viral load) and maintaining it through daily use of ART and regular checkups and laboratory monitori

Attending #HealtheVoices2017: a conference like no other.

published: April, 28, 2017 Written by // Rob Olver - Editor Categories // Activism, Social Media, Mental Health, Research, International , Living with HIV, Rob Olver - Editor

Rob Olver reports back on attending HealtheVoices17, a conference of online health advocates held in Chicago by Janssen & Janssen.

Attending #HealtheVoices2017: a conference like no other.

I applied, but didn't expect to go. HealtheVoices is a very different sort of conference to any of the others I’ve been to. It’s a conference of online patient health advocates, 105 of them this time, representing different chronic health conditions, HIV being just one. I was already aware of the conference due to PositiveLite.com’s Wayne Bristow and Bob Leahy having attended last year. They’d both had nothing but good to say about the experience and so, thinking, “Why the heck not

About the Positive Plus One Research Study

published: April, 26, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Research, Revolving Door, Living with HIV, Guest Authors

Positive and negative, have both your voices heard. Take the 30-minute online or telephone survey and receive a thank you gift card.

About the Positive Plus One Research Study

As HIV rates have stabilized, HIV-positive individuals are living longer lives. More and more people today are in relationships where one of the two people has HIV – this is known as an HIV-serodiscordant relationship. Many diseases can bring stress to a relationship, but the impact of HIV is potentially unique. People in serodiscordant relationships may face many challenges, including stigma, accommodating new HIV technologies, and the risk of transmission between partners. We are a group

Black gay men still at higher risk of HIV in the UK

published: April, 19, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, Gay Men, Mental Health, Research, Health, International , Revolving Door, Media, Guest Authors, Population Specific

From AIDSmap, Roger Pebody reports on a survey showing gay black men in the UK to also be at elevated risk of depression and suicidal thoughts.

Black gay men still at higher risk of HIV in the UK

Gay and bisexual men of black ethnicity are disproportionately likely to be living with diagnosed HIV than white British men, with no evidence that this health inequality has narrowed since 2001, according to a report published online ahead of print in Sexually Transmitted Infections. The data comes from the 2014 Gay Men’s Sex Survey, a convenience sample of 15,388 men recruited online. While 11.3% of white British men who had ever taken a test were diagnosed with HIV, this was the case

Attending CAHR2017 as a CATIE rapporteur

published: April, 13, 2017 Written by // Rob Olver - Editor Categories // Activism, African, Caribbean and Black, Aging, Social Media, Conferences, Gay Men, As Prevention , Youth, Treatment Guidelines -including when to start, Women, Mental Health, Health, Research, Legal, Treatment, Living with HIV, Opinion Pieces, Rob Olver - Editor

Rob Olver reports back on #CAHR2017

Attending CAHR2017 as a CATIE rapporteur

As I prepared to attend CAHR2017 in Montreal I was elated, but a bit nervous as well. I hadn’t qualified for a community scholarship but had been accepted as a CATIE rapporteur. This meant I’d be covering the event for CATIE as well as for PositiveLite.com and then on the final day, my fellow rapporteurs and I would present a report back to the rest of the conference with a distillation of what we’d seen and heard. So yes, I had butterflies, mostly because I haven’t done much science w

From the Conference on Retroviruses and Opportunistic Infections (CROI) 2017; new drugs, new hope and possible timelines

published: April, 07, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Gay Men, As Prevention , CATIE, Treatment Guidelines -including when to start, Research, CATIE - HIV and Hep C Info Resource, Treatment, Media

From CATIE, Sean R. Hosein reports on several new drugs that are in varying stages of development.

From the Conference on Retroviruses and Opportunistic Infections (CROI) 2017;  new drugs, new hope and possible timelines

Une version française est disponible ici. At the recent Conference on Retroviruses and Opportunistic Infections (CROI), which took place in Seattle from February 13 to 16, 2017, researchers presented data about new anti-HIV compounds in development, including the following: a new integrase inhibitor – bictegravir a new nuke (NRTI) – code-named GS-9131 a non-nuke (NNRTI) – doravirine a new protease inhibitor – code-named GS-PI1 a capsid inhibitor (a new cla

Investigating late HIV diagnoses as serious incidents may spur change across the health system.

published: April, 05, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, As Prevention , Newly Diagnosed, Treatment Guidelines -including when to start, General Health, Research, Health, International , Revolving Door, Treatment, Guest Authors, Media, Opinion Pieces

From AIDSmap, Roger Pebody on a report by public health officials and clinicians on a novel strategy to reduce very late HIV diagnosis in high-prevalence areas.

Investigating late HIV diagnoses as serious incidents may spur change across the health system.

Investigating cases of very late HIV diagnosis through the NHS’ serious incident reporting process allows identification of the reasons for late diagnosis and provides an impetus for initiatives to address them, public health officials and clinicians report in the March issue of the Journal of Public Health. In 2015 in the UK, 39% of adults were diagnosed with HIV infection at a late stage (below 350 CD4 cells/mm3) and 21% at a very late stage (below 200 CD4 cells/mm3). Late diagnosis of

Daily cannabis use has no negative Impact on HIV treatment

published: April, 04, 2017 Written by // Guest Authors - Revolving Door Categories // Alternative Therapies, Social Media, Health, Research, International , Revolving Door, Guest Authors

From Culture Magazine, this report on the ACCESS study, which monitored cannabis use among HIV patients.

Daily cannabis use has no negative Impact on HIV treatment

This article previously appeared at Culture Magazine, here. Daily cannabis use has little or no impact on HIV clinical outcomes, according to new research. A study was published in The International Journal of Drug Policy which suggests that heavy cannabis use does not pose a threat to those who are on HIV medications. Data was derived from the ACCESS study, which monitored drug use among HIV patients. Between 2005 and 2015, 874 HIV positive patients in Vancouver, Canada were observed b

<<  1 2 3 4 [56 7 8 9  >>  
Canadian Positive People Network/Reseau canadienne des personnes seropositives
Canadian Positive People Network/Reseau canadienne des personnes seropositives
GMRC
CATIE
The Village Pharmacy